2020年12月28日,Elevar Therapeutics宣布与Inceptua Group达成在欧洲分销和商业化Apealea®(紫杉醇胶束)的独家协议。Apealea已获得欧洲监管机构批准,与卡铂联用治疗首次复发的铂敏感性上皮性卵巢癌、原发性腹膜癌、输卵管癌成人患者。根据协...查看全文
$Oasmia药业(OASM)$ 424B3 Prospectus [Rule 424(b)(3)] Accession Number: 0001019155-19-000334 Act: 33 Size: 83 KB 网页链接
$Oasmia药业(OASM)$ F-6 POS Post-effective amendments for immediately effective filing Accession Number: 0001019155-19-000324 Act: 33 Size: 328 KB 网页链接
$Oasmia药业(OASM)$ 15F-12B - Securities registration termination of foreign private issuers [Section 12(b)] Filed: 2019-08-23 AccNo: 0001144204-19-041189 Size: 41 KB 网页链接
$Oasmia药业(OASM)$ 424B3 - Prospectus [Rule 424(b)(3)] Filed: 2019-08-23 AccNo: 0001019155-19-000204 Size: 83 KB 网页链接
$Oasmia药业(OASM)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2019-08-21 AccNo: 0001144204-19-040958 Size: 26 KB 网页链接
$Oasmia药业(OASM)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2019-08-15 AccNo: 0001144204-19-040265 Size: 25 KB 网页链接
$Oasmia药业(OASM)$ EFFECT - Notice of Effectiveness Filed: 2019-08-12 AccNo: 9999999995-19-001856 Size: 1 KB 网页链接
$Oasmia药业(OASM)$ 25 - Notification of the removal from listing and registration of matured, redeemed or retired securities Filed: 2019-08-13 AccNo: 0001144204-19-039257 Size: 13 KB 网页链接
$Oasmia药业(OASM)$ POS AM - Post-Effective amendments for registration statement Filed: 2019-08-08 AccNo: 0001144204-19-038564 Size: 20 KB 网页链接
$Oasmia药业(OASM)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2019-08-06 AccNo: 0001144204-19-037891 Size: 27 KB 网页链接